Sales Dropped For Hansen Natural

Hansen Natural Corp. (Nasdaq: HANS) said that sales dropped last month prompting Stifel Nicolaus analyst Mark Astrachan to lower his earnings estimates for 2009 as well as for 2010. The stock price tumbled $4.19 to close at $32.36.


About this Entry

This page contains a single entry by published on June 5, 2009 2:40 PM.

FDA Approves Palomar's Wrinkle Remover was the previous entry in this blog.

Human Genome Downgraded is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12